I rate Vistra Corp (VST) a Buy due to AI-driven power demand, robust fundamentals, and significant growth opportunities in the evolving energy landscape. VST benefits directly from surging data center and semiconductor fab electricity needs, as hyperscalers ramp up capital investment for AI and cloud projects. Strong partnerships and dispatchable generation assets, including nuclear, position VST as a reliable power supplier for tech companies seeking long-term contracts.

LOS ANGELES, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).

Cidara Therapeutics, Inc.'s CD388's strong phase 2b results significantly de-risk CDTX and highlight its potential as a superior flu prophylactic, especially for high-risk patients. Multiple short-term catalysts—including FDA meeting, BARDA funding, potential early start of phase 3 and breakthrough designation—could accelerate development and drive further upside. Cidara is well-funded through phase 3, with $516.9M in cash, and is an attractive acquisition candidate after its impressive trial results.

International Flavors debuts POWERFRESH ACE 2000, a bread enzyme that boosts softness, extends shelf life and supports bakery sustainability goals.

The long-running mystery around Warren Buffett's latest stealth investment is finally over. In Berkshire Hathaway's NYSE: BRK.B newest 13F filing, the Oracle of Omaha revealed a fresh stake in UnitedHealth Group Incorporated NYSE: UNH.

On 8/19/25, Chevron will trade ex-dividend, for its quarterly dividend of $1.71, payable on 9/10/25. As a percentage of CVX's recent stock price of $155.16, this dividend works out to approximately 1.10%, so look for shares of Chevron to trade 1.10% lower — all else being equal — when CVX shares open for trading on 8/19/25.

Registration Now Open for the Life Time Tropical 5K MIAMI , Aug. 15, 2025 /PRNewswire/ -- The 2026 Life Time Miami Marathon & Half presented by FP Movement has once again sold out – this time, two weeks sooner than the previous record sellout for last year's event, and just two weeks after registration opened to the public. Owned and produced by Life Time (NYSE: LTH), the nation's premier healthy lifestyle brand, registration for the January 25, 2026, event closed August 15 with 18,500 runners.

Does Consolidated Water (CWCO) have what it takes to be a top stock pick for momentum investors? Let's find out.

ISG (III) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

T. Rowe (TROW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Does UP Fintech Holding Limited (TIGR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Hillman Solutions Corp. (HLMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Celestica (CLS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Brixmor (BRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ACI Worldwide (ACIW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Does MAG Silver (MAG) have what it takes to be a top stock pick for momentum investors? Let's find out.

Banco Bradesco (BBD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Interactive Brokers Group, Inc. (IBKR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Armata Pharmaceuticals (ARMP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Dorman Products (DORM) have what it takes to be a top stock pick for momentum investors? Let's find out.